The combination of radiotherapy and anti-CTLA-4 therapy activates T cells with TCR against tumor cells repertoires and the combination of immune checkpoint inhibitor and radiation/chemotherapy has been clinically applied in unresectable stage III NSCLC (18, 137). Here, CTLA4 is linked to non-small cell lung carcinoma.